The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Cost-effectiveness of Prophylactic Antiemetic Therapy with Ondansetron, Droperidol, or Placebo
Open accessAbstract
Background: In an era of growing economic constraints on healthcare delivery, anesthesiologists are increasingly expected to understand cost analysis and evaluate clinical practices. Postoperative nausea and vomiting (PONV) are distressing for patients and may increase costs in an ambulatory surgical unit. The authors compared the cost-effectiveness of four prophylactic intravenous regimens for PONV: 4 mg ondansetron, 0.625 mg droperidol, 1.25 mg droperidol, and placebo. Methods: Adult surgical outpatients at high risk for PONV were studied. Study drugs were administered intravenously within 20 min of induction of nitrous oxide-isoflurane or enflurane anesthesia. A decision-tree analysis was used to group patients into 12 mutually exclusive subgroups based on treatment and outcome. Costs were calculated for the prevention and treatment of PONV. Cost-effectiveness analysis was performed for each group. Results: Two thousand sixty-one patients were enrolled. Efficacy data for study drugs have been previously reported, and the database from that study was used for pharmacoeconomic analysis. The mean-median total cost per patient who received prophylactic treatment with 4 mg ondansetron, 0.625 mg droperidol, 1.25 mg droperidol, and placebo were $112 or $16.44, $109 or $0.63, $104 or $0.51, and $164 or $51.20, respectively (P = 0.001, active treatment groups vs. placebo). The use of a prophylactic antiemetic agent significantly increased patient satisfaction (P < 0.05). Personnel costs in managing PONV and unexpected hospital admission constitute major cost components in our analysis. Exclusion of nursing labor costs from the calculation did not alter the overall conclusions regarding the relative costs of antiemetic therapy. Conclusion: The use of prophylactic antiemetic therapy in high-risk ambulatory surgical patients was more effective in preventing PONV and achieved greater patient satisfaction at a lower cost compared with placebo. The use of 1.25 mg droperidol intravenously was associated with greater effectiveness, lower costs, and similar patient satisfaction compared with 0.625 mg droperidol intravenously and 4 mg ondansetron intravenously.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cost-effective Management of Postoperative Nausea and Vomiting
Watcha, M. F. (2000) · Anesthesiology · doi:10.1097/00000542-200004000-00007 · Cited by 182
Postoperative Nausea and Vomiting: Prophylaxis Versus Treatment
White, P. F., & Watcha, M. F. (1999) · Anesthesia & Analgesia · doi:10.1097/00000539-199912000-00001 · Cited by 150
Cited by
Nygren, J., Thacker, J., Carli, F., Fearon, K. C. H., Norderval, S., Lobo, D. N., Ljungqvist, O., Soop, M., & Ramirez, J. (2013) · World Journal of Surgery · doi:10.1007/s00268-012-1787-6 · Cited by 2,171
Gustafsson, U. O., Scott, M. J., Hubner, M., Nygren, J., Demartines, N., Francis, N., Rockall, T. A., Young‐Fadok, T. M., Hill, A. G., Soop, M., et al. (2019) · World Journal of Surgery · doi:10.1007/s00268-018-4844-y · Cited by 2,119
A Factorial Trial of Six Interventions for the Prevention of Postoperative Nausea and Vomiting
Apfel, C. C., Korttila, K., Abdalla, M., Kerger, H., Turan, A., Vedder, I., Zernak, C., Danner, K., Jokela, R., Pocock, S. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032196 · Cited by 1,553
Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
Gan, T. J., Diemunsch, P., Habib, A. S., Kovac, A., Kranke, P., Meyer, T. A., Watcha, M., Chung, F., Angus, S., Apfel, C. C., et al. (2014) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000002 · Cited by 1,487
Self-citationFourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
Gan, T. J., Belani, K. G., Bergese, S., Chung, F., Diemunsch, P., Habib, A. S., Jin, Z., Kovac, A. L., Meyer, T. A., Urman, R. D., et al. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004833 · Cited by 1,295
Self-citation
Metadata
- Authors
- Hill, R. P., Lubarsky, D. A., Phillips-Bute, B., Fortney, J. T., Creed, M. R., Glass, P. S. A., & Gan, T. J.
- Venue
- Anesthesiology
- Published
- 2000-04-01
- Volume
- 92
- Issue
- 4
- Pages
- 958-967
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W1996131593
- Cited by
- 360
- References
- 2
- FWCI
- 21.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-effectiveness of Prophylactic Antiemetic Therapy with Ondansetron, Droperidol, or Placebo. https://app.cochat.ai/papers/10.1097/00000542-200004000-00012
- The paper
- Hill, R. P., Lubarsky, D. A., Phillips-Bute, B., Fortney, J. T., Creed, M. R., Glass, P. S. A., & Gan, T. J. (2000). Cost-effectiveness of Prophylactic Antiemetic Therapy with Ondansetron, Droperidol, or Placebo. Anesthesiology. https://doi.org/10.1097/00000542-200004000-00012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.